Hypopituitarism
ICD-10 E23.0 is a billable code used to indicate a diagnosis of hypopituitarism.
Hypopituitarism is a clinical condition characterized by the insufficient secretion of one or more of the hormones produced by the pituitary gland, which is a small gland located at the base of the brain. This condition can lead to a variety of hormonal deficiencies affecting multiple endocrine glands, including the adrenal glands, thyroid, and gonads. The causes of hypopituitarism can be diverse, including pituitary tumors, traumatic brain injury, infections, or congenital disorders. Patients may present with symptoms such as fatigue, weight loss, decreased libido, and sensitivity to cold, which are indicative of hormonal imbalances. The diagnosis is typically confirmed through hormonal assays and imaging studies, such as MRI, to assess the pituitary gland's structure. Treatment often involves hormone replacement therapy tailored to the specific deficiencies identified, which may include glucocorticoids for adrenal insufficiency, thyroid hormones, and sex hormones. Monitoring and adjusting therapy is crucial to managing this complex endocrine disorder effectively.
Detailed documentation of hormone assays, imaging results, and treatment plans.
Patients presenting with fatigue, weight changes, or sexual dysfunction requiring hormonal evaluation.
Endocrinologists must ensure all hormone deficiencies are documented and treated appropriately.
Documentation of neurological assessments and any imaging studies performed.
Patients with pituitary tumors or traumatic brain injuries affecting pituitary function.
Neurologists should document any neurological deficits that may relate to pituitary dysfunction.
Used to evaluate thyroid function in patients with suspected hypopituitarism.
Document the reason for testing and the patient's symptoms.
Endocrinologists should ensure comprehensive hormone panels are ordered.
Common symptoms include fatigue, weight gain or loss, decreased libido, sensitivity to cold, and menstrual irregularities in women.
Diagnosis typically involves a combination of clinical evaluation, hormonal assays to measure levels of pituitary hormones, and imaging studies such as MRI to assess the pituitary gland.
